DR.VANDEROOST SOFIE,ALGEMENE GENEESKUNDE
0807.688.019 · rovalta.com · 25/09/2026
DR.VANDEROOST SOFIE,ALGEMENE GENEESKUNDE
Financial year 2024 · Closed on 31/12/2024
Overview
Identity
Source · BCE/KBODR.VANDEROOST SOFIE,ALGEMENE GENEESKUNDE is a Private limited company incorporated in 2008. Its main activity is: General medical practice activities. Its registered office is in Dilbeek.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0807.688.019
- Incorporation
- 10/11/2008
- Legal form
- Private limited company
- Registered office
- Schorenbosstraat 8
1703 Dilbeek · FlandreSee on map - Latest accounts
- 31/12/2024
Financials
Source · NBB, 16 filingsTrend over 14 financial years
| 2024 | 2023 | 2022 | 2021 | 2018 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 99,5 k € | -1.5% | 100,9 k € | +18.1% | 85,5 k € | -30.4% | 122,9 k € | +116% | 56,9 k € |
| EBITDA | 98,1 k € | -1.6% | 99,7 k € | +17.9% | 84,5 k € | -30.7% | 121,9 k € | +190% | 42 k € |
| Operating result | 89,8 k € | +7.1% | 83,9 k € | +25.1% | 67 k € | -36.1% | 104,9 k € | +291% | 26,9 k € |
| Net result | 66,4 k € | +13.7% | 58,4 k € | +26.9% | 46 k € | -36.8% | 72,7 k € | +304% | 18 k € |
| Balance sheet | |||||||||
| Equity | 360,6 k € | +15.5% | 312,2 k € | +15.9% | 269,4 k € | +14.1% | 236 k € | +130% | 102,8 k € |
| Total assets | 384,1 k € | +14.2% | 336,3 k € | +16.8% | 287,9 k € | +11.0% | 259,3 k € | +112% | 122,2 k € |
| Cash | 159,6 k € | +192% | 54,7 k € | +57.6% | 34,7 k € | -35.4% | 53,7 k € | -41.1% | 91,3 k € |
| Debts | 12,2 k € | -34.4% | 18,6 k € | +0.4% | 18,5 k € | -20.2% | 23,2 k € | +19.7% | 19,4 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20241 active · 2 ended
Active mandates
Ended mandates
Other companies at this address
Schorenbosstraat 8 1703 Dilbeek| Company | CBE no. |
|---|---|
Grisez Sofie Huisarts● Active | 0537.373.169 |
Groepspraktijk Schorenbos● Active | 0665.819.282 |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 13/06/2025 | 16/07/2024 | 26/06/2023 | 22/06/2022 | 30/06/2021 | 28/08/2020 |
| General meeting | 23/05/2025 | 28/06/2024 | 26/05/2023 | 27/05/2022 | 28/05/2021 | 22/05/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 16 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2024 | 23/05/2025 | 13/06/2025 | Dutch | |
| Micro model | 31/12/2023 | 28/06/2024 | 16/07/2024 | Dutch | |
| Micro model | 31/12/2022 | 26/05/2023 | 26/06/2023 | Dutch | |
| Micro model | 31/12/2021 | 27/05/2022 | 22/06/2022 | Dutch | |
| Micro model | 31/12/2020 | 28/05/2021 | 30/06/2021 | Dutch | |
| Micro model | 31/12/2019 | 22/05/2020 | 28/08/2020 | Dutch | |
| Micro model | 31/12/2018 | 30/06/2019 | 31/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 25/05/2018 | 24/08/2018 | Dutch | |
| Micro model | 31/12/2016 | 26/05/2017 | 31/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 29/06/2016 | 29/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 22/05/2015 | 28/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 23/05/2014 | 28/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 24/05/2013 | 31/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 25/05/2012 | 05/07/2012 | Dutch | |
| Abridged model | 31/12/2010 | 27/05/2011 | 29/07/2011 | Dutch | |
| Abridged model | 31/12/2009 | 28/05/2010 | 25/08/2010 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active · 2 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 202466,4 k €↑
- 2023Annual accounts 202358,4 k €↑
- 2022Annual accounts 202246 k €↓
- 2021Annual accounts 202172,7 k €↑
- 2021Name changeDr. VANDEROOST SOFIE
- 2018Annual accounts 201818 k €↑
- 2017Annual accounts 201715,5 k €↑
- 2016Annual accounts 201612,7 k €↓
- 2015Annual accounts 201540,6 k €↓
- 2014Annual accounts 201447,4 k €↑
- 2013Annual accounts 201321,4 k €↓
- 2012Annual accounts 201241,4 k €↑
- 2011Annual accounts 201122,6 k €↑
- 2010Annual accounts 201012,7 k €↓
- 2009Annual accounts 200947,4 k €
- 2009Name changeDR.VANDEROOST SOFIE,ALGEMENE GENEESKUNDE
- 10/11/2008IncorporationPrivate limited company